Praesent dictum augue sit amet neque faucibus, ac varius enim convallis
These effects were achieved through the regulation of the Akt/mTOR/GSK-3 signaling pathway, positioning ESP as a promising therapeutic agent for addressing cognitive decline associated with AD (Luo et al., 2022)
Prucalopride is approved by the European Medicines Agency (EMA) and the FDA for the treatment of chronic constipation
Anti-inflammatory Activity This peptide may contribute to tissue healing by helping regulate the expression of genes involved in inflammation, oxidative stress, and immune response
Storage conditions in the real world vary widely (temperature fluctuations, humidity, light exposure, shipping conditions)
Most studies are small-scale, lack robust methodology, or have not been replicated in larger populations